Strategic Consulting · Decide with a path to execution

Make the next strategic decision easier to act on.

Lonrú helps life-science leaders translate complex evidence, market signals, and operating constraints into a decision that can be defended, with a practical route to making it real.

A senior advisor leads a life-science strategy discussion in an academic medical centre setting.

How we work

Strategic ConsultingLife-science strategy, governed delivery, and practical execution.
PhD and MBA-led Life Science Consultancy
Principal-led accountability

Scientific, commercial, and digital architecture, with specialist expertise assembled where the engagement requires it.

A useful starting point

Bring the decision that needs to withstand scientific, commercial, and operational scrutiny.

01

Commercialisation and value strategy

Clarify the route from scientific evidence to a credible value proposition, launch path, pricing model, or market-access decision.

02

Partnering and portfolio choices

Structure the evidence, narrative, and decision criteria needed for licensing, partnering, diligence, or portfolio prioritisation.

03

Operating-model and build-versus-buy decisions

Identify where a governed workflow, a bespoke tool, or a focused intervention will create more value than another static recommendation.

What the work leaves behind

A decision should leave the organisation better equipped to act.

Each engagement is designed around an output that can be used, governed, and improved after the initial work is complete.

  • Decision frameworks grounded in scientific and commercial evidence
  • Partner, investor, and executive narratives built around the real question
  • Prioritised operating and implementation roadmaps
  • Validated criteria for build, buy, integrate, or defer decisions

Relevant experience

Advanced therapy pricing and NPV decision systems

Lonrú has designed multi-dimensional pricing and Net Present Value models that connect clinical milestones, manufacturing COGs constraints, and quantified patient benefit for cell and gene therapy decisions.

A focused first conversation

Start with the decision or workflow that is proving hardest to move.

We’ll help identify the most useful next step and the right way to structure the work around it.

Request a briefing